0001127602-22-019824.txt : 20220727
0001127602-22-019824.hdr.sgml : 20220727
20220727193803
ACCESSION NUMBER: 0001127602-22-019824
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220725
FILED AS OF DATE: 20220727
DATE AS OF CHANGE: 20220727
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ACKERMANN CHRISTINA
CENTRAL INDEX KEY: 0001681871
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41380
FILM NUMBER: 221112343
MAIL ADDRESS:
STREET 1: C/O BLCO
STREET 2: 400 SOMERSET CORPORATE BLVD.
CITY: BRIDGEWATER
STATE: NJ
ZIP: 08807
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bausch & Lomb Corp
CENTRAL INDEX KEY: 0001860742
STANDARD INDUSTRIAL CLASSIFICATION: OPHTHALMIC GOODS [3851]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
BUSINESS PHONE: 908-541-5456
MAIL ADDRESS:
STREET 1: 520 APPLEWOOD CRESCENT
CITY: VAUGHAN
STATE: A6
ZIP: L4K 4B4
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2022-07-25
0001860742
Bausch & Lomb Corp
BLCO
0001681871
ACKERMANN CHRISTINA
C/O BAUSCH + LOMB CORPORATION
520 APPLEWOOD CRESCENT
VAUGHAN
A6
L4K4B4
ONTARIO, CANADA
1
Please see remarks
Common Shares, No Par Value
2022-07-25
4
A
0
35000
0
A
118333
D
Reflects the grant of restricted stock units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (the "Plan") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value ("Common Shares"), of Bausch + Lomb Corporation.
The Reporting Person's title as an officer of the Issuer is Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals.
/s/ Debra E. Levin, attorney-in-fact
2022-07-27